SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Oncology Institute, Inc.
@TOI_InsiderForm 4 Filing: Hively Brad Acquires (Grant) shares of $TOI
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Oncology Institute, Inc.
Ticker: $TOI
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-27
Shares: 27,108
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hively Brad, holds the title of Director at Oncology Institute, Inc..
On 2026-07-27, the insider transacted 27,108 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hively Brad (Director) was granted $0 of $TOI
Post-Transaction Position: 710,829 shares
SEC Accession No: 0001079973-26-000983 (CIK: 1891124)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.